Figure 3
From: Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors
KRT19 KO cells show defects in cell cycle progression. Cells were synchronized in serum-starved media for 48 h before treating them with 10% serum-containing media for 24 h. Cells were then fixed, nuclei stained with propidium iodide and analyzed using flow cytometry. Percentage of cells from four experimental repeats are shown as mean ± SEM. Differences are not statistically significant unless denoted by *p < 0.05; **p < 0.0005.
